Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Seelos Therapeutics Inc (SEEL)

Seelos Therapeutics Inc (SEEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cancer Biology Clinical Research Seeking Answers at Cellular Level

Research for the cure for cancer has become this generation's version of President John F. Kennedy's May 25, 1961 proclamation to "Landing a man on the Moon and returning him safely". Much money and effort...

MBRX : 1.02 (+0.99%)
SEEL : 1.12 (-3.45%)
BMY : 63.82 (-0.19%)
CPRX : 4.43 (+2.55%)
CCXI : 31.41 (-5.62%)
Accelerated Clinical Trials Bridging Gateway to Latest Treatments for Cancer Patients

Cancer research has for years been steadily gaining ground on its way to managing, curing and even preventing the various forms of this insidious disease. Both public and private money continues to flow...

MBRX : 1.02 (+0.99%)
SEEL : 1.12 (-3.45%)
ELAN : 27.78 (+1.09%)
AKBA : 6.39 (+0.63%)
PFE : 38.33 (-0.54%)
FDA Regulations Allow Medical Devices Clinical Trials to Differ From Pharmaceutical Trials

Clinical trials are the pathway for new drugs or devices to enter the U.S. and other worldwide markets. However, not all clinical trials are the same. A recent article by a 20+ year insider in the clinical...

SOLY : 10.32 (unch)
BPTH : 7.66 (-0.65%)
ARQL : 20.07 (+0.38%)
SEEL : 1.12 (-3.45%)
LLY : 121.53 (-0.14%)
Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma

Diversifies Seelos' pipeline in rare diseases

SEEL : 1.12 (-3.45%)
ORPN : 11.50 (+6.68%)
Bioblast Pharma Announces Sale of its Trehalose Clinical Development Programs to Seelos Therapeutics

-- Unconditional payment of $3.5 million

ORPN : 11.50 (+6.68%)
SEEL : 1.12 (-3.45%)
Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients...

SEEL : 1.12 (-3.45%)
APRI : 0.22 (-4.35%)
LGND : 106.04 (-0.75%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.68 , AIZ -0.29 , SBAC +7.43 , SO +0.05 , WELL -0.46
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar